Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

Wind-down of stem-cell institute leaves a void.

Loring JF.

Nature. 2019 Aug;572(7768):155. doi: 10.1038/d41586-019-02346-5. No abstract available.

PMID:
31391566
2.

A Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017.

Kim JH, Alderton A, Crook JM, Benvenisty N, Brandsten C, Firpo M, Harrison PW, Kawamata S, Kawase E, Kurtz A, Loring JF, Ludwig T, Man J, Mountford JC, Turner ML, Oh S, da Veiga Pereira L, Pranke P, Sheldon M, Steeg R, Sullivan S, Yaffe M, Zhou Q, Stacey GN.

Stem Cells. 2019 Sep;37(9):1130-1135. doi: 10.1002/stem.3003. Epub 2019 Aug 6.

PMID:
31021472
3.

Reducing Mcl-1 gene dosage induces dopaminergic neuronal loss and motor impairments in Park2 knockout mice.

Ekholm-Reed S, Baker R, Campos AR, Stouffer D, Henze M, Wolf DA, Loring JF, Thomas EA, Reed SI.

Commun Biol. 2019 Apr 4;2:125. doi: 10.1038/s42003-019-0366-x. eCollection 2019.

4.

Human Pluripotent Stem Cell-Derived Multipotent Vascular Progenitors of the Mesothelium Lineage Have Utility in Tissue Engineering and Repair.

Colunga T, Hayworth M, Kreß S, Reynolds DM, Chen L, Nazor KL, Baur J, Singh AM, Loring JF, Metzger M, Dalton S.

Cell Rep. 2019 Mar 5;26(10):2566-2579.e10. doi: 10.1016/j.celrep.2019.02.016.

5.

Ethical Considerations in the Manufacture, Sale, and Distribution of Genome Editing Technologies.

Sugarman J, Shivakumar S, Rook M, Loring JF, Rehmann-Sutter C, Taupitz J, Reinhard-Rupp J, Hildemann S.

Am J Bioeth. 2018 Aug;18(8):3-6. doi: 10.1080/15265161.2018.1489653. No abstract available.

PMID:
30133390
6.

Promoting remyelination through cell transplantation therapies in a model of viral-induced neurodegenerative disease.

Mangale V, McIntyre LL, Walsh CM, Loring JF, Lane TE.

Dev Dyn. 2019 Jan;248(1):43-52. doi: 10.1002/dvdy.24658. Epub 2018 Sep 6. Review.

7.

Autologous Induced Pluripotent Stem Cell-Derived Neurons to Treat Parkinson's Disease.

Loring JF.

Stem Cells Dev. 2018 Jul 15;27(14):958-959. doi: 10.1089/scd.2018.0107. Epub 2018 Jun 18.

PMID:
29790422
8.

A Standard Nomenclature for Referencing and Authentication of Pluripotent Stem Cells.

Kurtz A, Seltmann S, Bairoch A, Bittner MS, Bruce K, Capes-Davis A, Clarke L, Crook JM, Daheron L, Dewender J, Faulconbridge A, Fujibuchi W, Gutteridge A, Hei DJ, Kim YO, Kim JH, Kokocinski AK, Lekschas F, Lomax GP, Loring JF, Ludwig T, Mah N, Matsui T, Müller R, Parkinson H, Sheldon M, Smith K, Stachelscheid H, Stacey G, Streeter I, Veiga A, Xu RH.

Stem Cell Reports. 2018 Jan 9;10(1):1-6. doi: 10.1016/j.stemcr.2017.12.002. Review.

9.

Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells.

Kim JH, Kurtz A, Yuan BZ, Zeng F, Lomax G, Loring JF, Crook J, Ju JH, Clarke L, Inamdar MS, Pera M, Firpo MT, Sheldon M, Rahman N, O'Shea O, Pranke P, Zhou Q, Isasi R, Rungsiwiwut R, Kawamata S, Oh S, Ludwig T, Masui T, Novak TJ, Takahashi T, Fujibuchi W, Koo SK, Stacey GN.

Stem Cells Transl Med. 2017 Nov;6(11):1956-1962. doi: 10.1002/sctm.17-0144. Epub 2017 Oct 24.

10.

iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across a Variety of Cell Types.

Panopoulos AD, D'Antonio M, Benaglio P, Williams R, Hashem SI, Schuldt BM, DeBoever C, Arias AD, Garcia M, Nelson BC, Harismendy O, Jakubosky DA, Donovan MKR, Greenwald WW, Farnam K, Cook M, Borja V, Miller CA, Grinstein JD, Drees F, Okubo J, Diffenderfer KE, Hishida Y, Modesto V, Dargitz CT, Feiring R, Zhao C, Aguirre A, McGarry TJ, Matsui H, Li H, Reyna J, Rao F, O'Connor DT, Yeo GW, Evans SM, Chi NC, Jepsen K, Nariai N, Müller FJ, Goldstein LSB, Izpisua Belmonte JC, Adler E, Loring JF, Berggren WT, D'Antonio-Chronowska A, Smith EN, Frazer KA.

Stem Cell Reports. 2017 Apr 11;8(4):1086-1100. doi: 10.1016/j.stemcr.2017.03.012.

11.

Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome.

Boland MJ, Nazor KL, Tran HT, Szücs A, Lynch CL, Paredes R, Tassone F, Sanna PP, Hagerman RJ, Loring JF.

Brain. 2017 Mar 1;140(3):582-598. doi: 10.1093/brain/aww357.

12.

New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells.

O'Brien CM, Chy HS, Zhou Q, Blumenfeld S, Lambshead JW, Liu X, Kie J, Capaldo BD, Chung TL, Adams TE, Phan T, Bentley JD, McKinstry WJ, Oliva K, McMurrick PJ, Wang YC, Rossello FJ, Lindeman GJ, Chen D, Jarde T, Clark AT, Abud HE, Visvader JE, Nefzger CM, Polo JM, Loring JF, Laslett AL.

Stem Cells. 2017 Mar;35(3):626-640. doi: 10.1002/stem.2558. Epub 2017 Jan 19.

13.

Spontaneous Single-Copy Loss of TP53 in Human Embryonic Stem Cells Markedly Increases Cell Proliferation and Survival.

Amir H, Touboul T, Sabatini K, Chhabra D, Garitaonandia I, Loring JF, Morey R, Laurent LC.

Stem Cells. 2017 Apr;35(4):872-885. doi: 10.1002/stem.2550. Epub 2017 Jan 19.

14.

The tumorigenic potential of pluripotent stem cells: What can we do to minimize it?

Peterson SE, Garitaonandia I, Loring JF.

Bioessays. 2016 Jul;38 Suppl 1:S86-95. doi: 10.1002/bies.201670915. Review.

PMID:
27417126
15.

Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis.

Plaisted WC, Zavala A, Hingco E, Tran H, Coleman R, Lane TE, Loring JF, Walsh CM.

PLoS One. 2016 Jun 16;11(6):e0157620. doi: 10.1371/journal.pone.0157620. eCollection 2016.

16.

Rewinding the process of mammalian extinction.

Saragusty J, Diecke S, Drukker M, Durrant B, Friedrich Ben-Nun I, Galli C, Göritz F, Hayashi K, Hermes R, Holtze S, Johnson S, Lazzari G, Loi P, Loring JF, Okita K, Renfree MB, Seet S, Voracek T, Stejskal J, Ryder OA, Hildebrandt TB.

Zoo Biol. 2016 Jul;35(4):280-92. doi: 10.1002/zoo.21284. Epub 2016 May 3.

PMID:
27142508
17.

Whole-genome mutational burden analysis of three pluripotency induction methods.

Bhutani K, Nazor KL, Williams R, Tran H, Dai H, Džakula Ž, Cho EH, Pang AWC, Rao M, Cao H, Schork NJ, Loring JF.

Nat Commun. 2016 Feb 19;7:10536. doi: 10.1038/ncomms10536.

18.

Generation of Induced Pluripotent Stem Cells from Mammalian Endangered Species.

Ben-Nun IF, Montague SC, Houck ML, Ryder O, Loring JF.

Methods Mol Biol. 2015;1330:101-9. doi: 10.1007/978-1-4939-2848-4_10.

PMID:
26621593
19.

Human stem cells from single blastomeres reveal pathways of embryonic or trophoblast fate specification.

Zdravkovic T, Nazor KL, Larocque N, Gormley M, Donne M, Hunkapillar N, Giritharan G, Bernstein HS, Wei G, Hebrok M, Zeng X, Genbacev O, Mattis A, McMaster MT, Krtolica A, Valbuena D, Simón C, Laurent LC, Loring JF, Fisher SJ.

Development. 2015 Dec 1;142(23):4010-25. doi: 10.1242/dev.122846. Epub 2015 Oct 19.

20.

Glycosyltransferase ST6GAL1 contributes to the regulation of pluripotency in human pluripotent stem cells.

Wang YC, Stein JW, Lynch CL, Tran HT, Lee CY, Coleman R, Hatch A, Antontsev VG, Chy HS, O'Brien CM, Murthy SK, Laslett AL, Peterson SE, Loring JF.

Sci Rep. 2015 Aug 25;5:13317. doi: 10.1038/srep13317.

Supplemental Content

Loading ...
Support Center